The Long View: 2-Year Outcomes of Mirikizumab for Ulcerative Colitis. Pillay L, Subramanian S. Inflamm Bowel Dis 2024 Mar 7:izae025. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pillay L, Subramanian S. The Long View: 2-Year Outcomes of Mirikizumab for Ulcerative Colitis. Inflamm Bowel Dis 2024 Mar 7:izae025. doi: 10.1093.
PMID: 38452032